199 related articles for article (PubMed ID: 37932299)
1. Integration of risk variants from GWAS with SARS-CoV-2 RNA interactome prioritizes FUBP1 and RAB2A as risk genes for COVID-19.
Shi W; Chen M; Pan T; Chen M; Cheng Y; Hao Y; Chen S; Tang Y
Sci Rep; 2023 Nov; 13(1):19194. PubMed ID: 37932299
[TBL] [Abstract][Full Text] [Related]
2. Global analysis of protein-RNA interactions in SARS-CoV-2-infected cells reveals key regulators of infection.
Kamel W; Noerenberg M; Cerikan B; Chen H; Järvelin AI; Kammoun M; Lee JY; Shuai N; Garcia-Moreno M; Andrejeva A; Deery MJ; Johnson N; Neufeldt CJ; Cortese M; Knight ML; Lilley KS; Martinez J; Davis I; Bartenschlager R; Mohammed S; Castello A
Mol Cell; 2021 Jul; 81(13):2851-2867.e7. PubMed ID: 34118193
[TBL] [Abstract][Full Text] [Related]
3. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response.
Enguita FJ; Leitão AL; McDonald JT; Zaksas V; Das S; Galeano D; Taylor D; Wurtele ES; Saravia-Butler A; Baylin SB; Meller R; Porterfield DM; Wallace DC; Schisler JC; Mason CE; Beheshti A
Theranostics; 2022; 12(8):3946-3962. PubMed ID: 35664076
[No Abstract] [Full Text] [Related]
4. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.
Srivastava R; Daulatabad SV; Srivastava M; Janga SC
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993015
[TBL] [Abstract][Full Text] [Related]
5. The SARS-CoV-2 RNA interactome.
Lee S; Lee YS; Choi Y; Son A; Park Y; Lee KM; Kim J; Kim JS; Kim VN
Mol Cell; 2021 Jul; 81(13):2838-2850.e6. PubMed ID: 33989516
[TBL] [Abstract][Full Text] [Related]
6. Characterization and functional interrogation of the SARS-CoV-2 RNA interactome.
Labeau A; Fery-Simonian L; Lefevre-Utile A; Pourcelot M; Bonnet-Madin L; Soumelis V; Lotteau V; Vidalain PO; Amara A; Meertens L
Cell Rep; 2022 Apr; 39(4):110744. PubMed ID: 35477000
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.
Jiang L; Xiao M; Liao QQ; Zheng L; Li C; Liu Y; Yang B; Ren A; Jiang C; Feng XH
mSystems; 2023 Aug; 8(4):e0013523. PubMed ID: 37314180
[TBL] [Abstract][Full Text] [Related]
8. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
9. ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19.
Pietzner M; Chua RL; Wheeler E; Jechow K; Willett JDS; Radbruch H; Trump S; Heidecker B; Zeberg H; Heppner FL; Eils R; Mall MA; Richards JB; Sander LE; Lehmann I; Lukassen S; Wareham NJ; Conrad C; Langenberg C
Nat Commun; 2022 Aug; 13(1):4484. PubMed ID: 35970849
[TBL] [Abstract][Full Text] [Related]
10. CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1.
Fink-Baldauf IM; Stuart WD; Brewington JJ; Guo M; Maeda Y
EBioMedicine; 2022 Jan; 75():103806. PubMed ID: 34998241
[TBL] [Abstract][Full Text] [Related]
11. Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication.
Moll T; Odon V; Harvey C; Collins MO; Peden A; Franklin J; Graves E; Marshall JN; Dos Santos Souza C; Zhang S; Castelli L; Hautbergue G; Azzouz M; Gordon D; Krogan N; Ferraiuolo L; Snyder MP; Shaw PJ; Rehwinkel J; Cooper-Knock J
Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36241425
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.
Hahn G; Wu CM; Lee S; Lutz SM; Khurana S; Baden LR; Haneuse S; Qiao D; Hecker J; DeMeo DL; Tanzi RE; Choudhary MC; Etemad B; Mohammadi A; Esmaeilzadeh E; Cho MH; Li JZ; Randolph AG; Laird NM; Weiss ST; Silverman EK; Ribbeck K; Lange C
Genet Epidemiol; 2021 Oct; 45(7):685-693. PubMed ID: 34159627
[TBL] [Abstract][Full Text] [Related]
13. A proposed molecular mechanism for pathogenesis of severe RNA-viral pulmonary infections.
Rogan PK; Mucaki EJ; Shirley BC
F1000Res; 2020; 9():943. PubMed ID: 33299552
[No Abstract] [Full Text] [Related]
14. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.
D'Antonio M; Nguyen JP; Arthur TD; Matsui H; ; D'Antonio-Chronowska A; Frazer KA
Cell Rep; 2021 Nov; 37(7):110020. PubMed ID: 34762851
[TBL] [Abstract][Full Text] [Related]
15. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Pairo-Castineira E; Rawlik K; Bretherick AD; Qi T; Wu Y; Nassiri I; McConkey GA; Zechner M; Klaric L; Griffiths F; Oosthuyzen W; Kousathanas A; Richmond A; Millar J; Russell CD; Malinauskas T; Thwaites R; Morrice K; Keating S; Maslove D; Nichol A; Semple MG; Knight J; Shankar-Hari M; Summers C; Hinds C; Horby P; Ling L; McAuley D; Montgomery H; Openshaw PJM; Begg C; Walsh T; Tenesa A; Flores C; Riancho JA; Rojas-Martinez A; Lapunzina P; ; ; ; ; Yang J; Ponting CP; Wilson JF; Vitart V; Abedalthagafi M; Luchessi AD; Parra EJ; Cruz R; Carracedo A; Fawkes A; Murphy L; Rowan K; Pereira AC; Law A; Fairfax B; Hendry SC; Baillie JK
Nature; 2023 May; 617(7962):764-768. PubMed ID: 37198478
[TBL] [Abstract][Full Text] [Related]
16. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
17. Exploring COVID-19 causal genes through disease-specific Cis-eQTLs.
Zhang S; Wang P; Shi L; Wang C; Zhu Z; Qi C; Xie Y; Yuan S; Cheng L; Yin X; Zhang X
Virus Res; 2024 Apr; 342():199341. PubMed ID: 38403000
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis.
Ferrarini MG; Lal A; Rebollo R; Gruber AJ; Guarracino A; Gonzalez IM; Floyd T; de Oliveira DS; Shanklin J; Beausoleil E; Pusa T; Pickett BE; Aguiar-Pulido V
Commun Biol; 2021 May; 4(1):590. PubMed ID: 34002013
[TBL] [Abstract][Full Text] [Related]
19. Role of SARS-CoV-2 in altering the RNA binding protein and miRNA directed post-transcriptional regulatory networks in humans.
Srivastava R; Daulatabad SV; Srivastava M; Janga SC
bioRxiv; 2020 Sep; ():. PubMed ID: 32676599
[TBL] [Abstract][Full Text] [Related]
20. Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2
Chang JJ; Gleeson J; Rawlinson D; De Paoli-Iseppi R; Zhou C; Mordant FL; Londrigan SL; Clark MB; Subbarao K; Stinear TP; Coin LJM; Pitt ME
Front Immunol; 2022; 13():832223. PubMed ID: 35464437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
